Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Cardiff Oncology Inc (CRDF)

Cardiff Oncology Inc (CRDF)
3.22 +0.17 (+5.57%) 09:50 ET [NASDAQ]
3.21 x 400 3.22 x 100
Realtime by (Cboe BZX)
3.21 x 400 3.22 x 100
Realtime 3.20 +0.15 (+4.92%) 09:25 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
3.18
Day High
3.28
Open 3.18
Previous Close 3.05 3.05
Volume 61,496 61,496
Avg Vol 1,475,790 1,475,790
Stochastic %K 84.09% 84.09%
Weighted Alpha -41.69 -41.69
5-Day Change +0.30 (+10.20%) +0.30 (+10.20%)
52-Week Range 2.01 - 5.64 2.01 - 5.64
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 202,898
  • Shares Outstanding, K 66,524
  • Annual Sales, $ 680 K
  • Annual Income, $ -45,430 K
  • EBIT $ -49 M
  • EBITDA $ -49 M
  • 60-Month Beta 1.74
  • Price/Sales 274.67
  • Price/Cash Flow N/A
  • Price/Book 1.52

Options Overview Details

View History
  • Implied Volatility 257.46% ( +109.71%)
  • Historical Volatility 85.94%
  • IV Percentile 87%
  • IV Rank 38.13%
  • IV High 628.39% on 09/18/24
  • IV Low 28.90% on 05/22/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 259
  • Volume Avg (30-Day) 598
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 30,585
  • Open Int (30-Day) 26,718

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.19
  • Number of Estimates 4
  • High Estimate -0.14
  • Low Estimate -0.23
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.36 +37.29%
on 04/11/25
Period Open: 3.75
3.86 -15.95%
on 03/24/25
-0.51 (-13.60%)
since 03/21/25
3-Month
2.36 +37.29%
on 04/11/25
Period Open: 3.50
4.99 -35.07%
on 02/21/25
-0.26 (-7.43%)
since 01/23/25
52-Week
2.01 +61.19%
on 08/05/24
Period Open: 4.17
5.64 -42.55%
on 12/17/24
-0.93 (-22.30%)
since 04/23/24

Most Recent Stories

More News
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CRDF : 3.22 (+5.57%)
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

CRDF : 3.22 (+5.57%)
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge

/CNW/ -- As the global cancer crisis intensifies, the demand for breakthrough treatments is reaching new heights. Statista data projects a 20% rise in annual...

ONCY : 0.6004 (+0.37%)
EXEL : 36.94 (+1.26%)
ONC.TO : 0.82 (-2.38%)
ALXO : 0.6413 (+8.16%)
CRDF : 3.22 (+5.57%)
VSTM : 7.08 (+0.57%)
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

CRDF : 3.22 (+5.57%)
Cardiff Oncology to Present at Upcoming Investor Conferences

CRDF : 3.22 (+5.57%)
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update

CRDF : 3.22 (+5.57%)
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NYSE:ABBV),(NASDAQ:CRDF) EQNX::TICKER_END

ONCY : 0.6004 (+0.37%)
AZN : 68.70 (+1.22%)
ABBV : 176.79 (+1.73%)
ONC.TO : 0.82 (-2.38%)
GSK : 37.02 (+1.06%)
CRDF : 3.22 (+5.57%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END

ONCY : 0.6004 (+0.37%)
CKPT : 4.05 (+0.12%)
PSNL : 3.75 (+9.97%)
ONC.TO : 0.82 (-2.38%)
TEM : 49.58 (+14.69%)
CRDF : 3.22 (+5.57%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

/CNW/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights, underscoring major...

ONCY : 0.6004 (+0.37%)
CKPT : 4.05 (+0.12%)
PSNL : 3.75 (+9.97%)
ONC.TO : 0.82 (-2.38%)
TEM : 49.58 (+14.69%)
CRDF : 3.22 (+5.57%)
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments

/CNW/ -- USA News Group News Commentary – The American Cancer Society recently released its Advances in Oncology – 2024 Research Highlights report that...

ONCY : 0.6004 (+0.37%)
CKPT : 4.05 (+0.12%)
LLY : 836.68 (+1.10%)
ONC.TO : 0.82 (-2.38%)
OSTX : 1.5800 (+3.95%)
CRDF : 3.22 (+5.57%)

Business Summary

Cardiff Oncology Inc. is a clinical-stage biotechnology company. It engages in developing treatment for cancer patients. The company's product pipeline consists of a Phase 1b/2 study of onvansertib in combination with FOLFIRI/Avastin(R) in KRAS-mutated metastatic colorectal cancer; a Phase 2 study of...

See More

Key Turning Points

3rd Resistance Point 3.34
2nd Resistance Point 3.21
1st Resistance Point 3.13
Last Price 3.22
1st Support Level 2.92
2nd Support Level 2.79
3rd Support Level 2.71

See More

52-Week High 5.64
Fibonacci 61.8% 4.25
Fibonacci 50% 3.82
Fibonacci 38.2% 3.40
Last Price 3.22
52-Week Low 2.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro